ZA200906574B - Method to modulate hematopoietic stem cell growth - Google Patents
Method to modulate hematopoietic stem cell growthInfo
- Publication number
- ZA200906574B ZA200906574B ZA200906574A ZA200906574A ZA200906574B ZA 200906574 B ZA200906574 B ZA 200906574B ZA 200906574 A ZA200906574 A ZA 200906574A ZA 200906574 A ZA200906574 A ZA 200906574A ZA 200906574 B ZA200906574 B ZA 200906574B
- Authority
- ZA
- South Africa
- Prior art keywords
- stem cell
- cell growth
- hematopoietic stem
- modulate hematopoietic
- modulate
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/48—Reproductive organs
- A61K35/50—Placenta; Placental stem cells; Amniotic fluid; Amnion; Amniotic stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0647—Haematopoietic stem cells; Uncommitted or multipotent progenitors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/02—Compounds of the arachidonic acid pathway, e.g. prostaglandins, leukotrienes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Cell Biology (AREA)
- Developmental Biology & Embryology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Virology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pregnancy & Childbirth (AREA)
- Reproductive Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Materials For Medical Uses (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US78596806P | 2006-03-24 | 2006-03-24 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA200906574B true ZA200906574B (en) | 2010-06-30 |
Family
ID=38526581
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA200808123A ZA200808123B (en) | 2006-03-24 | 2007-03-26 | Method to modulate hematopoietic stem cell growth |
ZA200906574A ZA200906574B (en) | 2006-03-24 | 2009-09-21 | Method to modulate hematopoietic stem cell growth |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA200808123A ZA200808123B (en) | 2006-03-24 | 2007-03-26 | Method to modulate hematopoietic stem cell growth |
Country Status (11)
Country | Link |
---|---|
US (7) | US8168428B2 (xx) |
EP (3) | EP1999255A2 (xx) |
JP (8) | JP5247675B2 (xx) |
CN (2) | CN102626517B (xx) |
AU (1) | AU2007230902B2 (xx) |
CA (1) | CA2647201C (xx) |
HK (1) | HK1173948A1 (xx) |
MX (2) | MX2008012178A (xx) |
RU (2) | RU2493252C2 (xx) |
WO (1) | WO2007112084A2 (xx) |
ZA (2) | ZA200808123B (xx) |
Families Citing this family (58)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102626517B (zh) | 2006-03-24 | 2015-07-29 | 儿童医疗中心有限公司 | 调节造血干细胞生长的方法 |
EP2077826B1 (en) * | 2006-10-20 | 2013-09-04 | Children's Medical Center Corporation | Method to enhance tissue regeneration |
US9394520B2 (en) | 2006-12-08 | 2016-07-19 | University Of Rochester | Expansion of hematopoietic stem cells |
WO2008133904A1 (en) * | 2007-04-23 | 2008-11-06 | Stowers Institute For Medical Research | Methods and compositions for stem cell self-renewal |
US8871752B2 (en) * | 2008-02-19 | 2014-10-28 | Sucampo Ag | Method for modulating stem cell growth |
ITUD20080058A1 (it) | 2008-03-18 | 2009-09-19 | Thankstem S R L | Kit per la raccolta di sangue, preferibilmente periferico, per la produzione di cellule staminali |
WO2009155041A2 (en) * | 2008-05-28 | 2009-12-23 | Children's Medical Center Corporation | Method to modulate hematopoietic stem cell growth |
CA3203374A1 (en) | 2008-11-06 | 2010-05-14 | Indiana University Research & Technology Corporation | Materials and methods to enhance hematopoietic stem cells engraftment procedures |
WO2010096264A2 (en) | 2009-02-03 | 2010-08-26 | Children's Medical Center Corporation | Methods for enhancing hematopoietic stem/progenitor cell engraftment |
WO2010091052A2 (en) | 2009-02-03 | 2010-08-12 | Children's Medical Center Corporation | Methods for enhancing hematopoietic stem/progenitor cell engraftment |
JP5836262B2 (ja) * | 2009-03-19 | 2015-12-24 | フェイト セラピューティクス, インコーポレイテッド | サイクリックampエンハンサーおよび/またはepリガンドを含む組成物、ならびにこれを調製および使用する方法 |
WO2010121122A2 (en) * | 2009-04-17 | 2010-10-21 | The Brigham And Women's Hospital, Inc. | Biomechanical induction of hematopoiesis |
EP2251010A1 (en) | 2009-05-08 | 2010-11-17 | Sygnis Bioscience GmbH & Co. KG | Use of thiabendazole and derivatives thereof for the therapy of neurological conditions |
JP6037836B2 (ja) * | 2009-11-15 | 2016-12-07 | インディアナ・ユニバーシティ・リサーチ・アンド・テクノロジー・コーポレーション | 特異的プロスタグランジンe2受容体の特定を含む幹細胞の送達及び生着を高めるための方法 |
WO2011062584A1 (en) * | 2009-11-19 | 2011-05-26 | Regents Of The University Of Minnesota | Reducing inflammation using cell therapy |
EP2569412A4 (en) * | 2010-05-10 | 2017-03-01 | Fate Therapeutics, Inc. | Biovessels |
US20140030232A1 (en) * | 2010-08-12 | 2014-01-30 | Fate Therapeutics, Inc. | Hematopoietic stem and progenitor cell therapy |
SG191908A1 (en) | 2011-01-13 | 2013-08-30 | Scipharm Sarl | Method for enhancing engraftment of haematopoetic stem cells |
EP2701694A4 (en) | 2011-04-28 | 2014-10-08 | Univ Duke | METHOD FOR THE TREATMENT OF HEMOGLOBINOPATHIES |
BR112014007782B1 (pt) | 2011-09-30 | 2021-06-01 | Bluebird Bio, Inc. | Método para aumentar a eficiência de transdução lentiviral de células progenitoras ou células-tronco hematopoiéticas cd34+, bem como usos terapêuticos de composição compreendendo as ditas células e de pge2, 16,16-dimetil pge2, ou seu análogo |
CA2857640C (en) | 2011-12-02 | 2021-11-16 | Fate Therapeutics, Inc. | Enhanced stem cell composition |
ES2682255T3 (es) | 2011-12-02 | 2018-09-19 | Fate Therapeutics, Inc. | Métodos mejorados de tratamiento de isquemia |
US9428732B2 (en) | 2011-12-05 | 2016-08-30 | Primorigen Biosciences, Inc. | Compositions and methods for differentiating pluripotent stem cells into primitive blood cells and uses thereof |
WO2014015318A1 (en) * | 2012-07-19 | 2014-01-23 | Bluebird Bio, Inc. | Soluble compounds for improved gene therapy methods |
US9861685B2 (en) | 2012-11-20 | 2018-01-09 | Duke University | Methods of treating hemoglobinopathies |
WO2014150602A1 (en) | 2013-03-15 | 2014-09-25 | Fate Therapeutics, Inc. | Cell potency assay for therapeutic potential |
US9943545B2 (en) | 2013-03-15 | 2018-04-17 | Fate Therapeutics, Inc. | Stem cell culture media and methods of enhancing cell survival |
US9428748B2 (en) * | 2013-06-17 | 2016-08-30 | Hong Gao | Method of expanding hematopoietic stem cells |
JP2015205835A (ja) * | 2014-04-21 | 2015-11-19 | 国立大学法人福井大学 | 中性子線障害防護剤 |
EP3134096A4 (en) * | 2014-04-23 | 2018-01-10 | Texas Heart Institute | Methods of enhancing stem cell engraftment |
US9816074B2 (en) | 2014-07-25 | 2017-11-14 | Sangamo Therapeutics, Inc. | Methods and compositions for modulating nuclease-mediated genome engineering in hematopoietic stem cells |
LT3194570T (lt) | 2014-09-16 | 2021-09-27 | Sangamo Therapeutics, Inc. | Būdai ir kompozicijos, skirti kraujodaros kamieninių ląstelių genomo inžinerijai ir korekcijai, kuriai tarpininkauja nukleazė |
AU2016211671B2 (en) | 2015-01-26 | 2022-05-26 | Fate Therapeutics, Inc. | Methods and compositions for inducing hematopoietic cell differentiation |
JP6980534B2 (ja) | 2015-06-25 | 2021-12-15 | ザ チルドレンズ メディカル センター コーポレーション | 造血幹細胞の増大、富化、および維持に関する方法および組成物 |
AU2016296741A1 (en) | 2015-07-21 | 2018-02-22 | The Children's Medical Center Corporation | PD-L1 expressing hematopoietic stem cells and uses |
CN105296427A (zh) * | 2015-10-23 | 2016-02-03 | 深圳爱生再生医学科技有限公司 | 造血干细胞的体外扩增培养方法 |
JP7189587B2 (ja) * | 2015-10-30 | 2022-12-14 | 典正 三浦 | メチル化関連酵素hat1とkat8の阻害薬 |
CA3003150A1 (en) | 2015-11-04 | 2017-05-11 | Fate Therapeutics, Inc. | Genomic engineering of pluripotent cells |
EP3371301A4 (en) | 2015-11-04 | 2019-06-26 | Fate Therapeutics, Inc. | METHOD AND COMPOSITIONS FOR INDUCING THE DIFFERENTIATION OF HEMATOPOIETIC CELLS |
CN108713059A (zh) | 2016-02-12 | 2018-10-26 | 蓝鸟生物公司 | Vcn增强子组合物和其使用方法 |
US11326183B2 (en) | 2016-02-12 | 2022-05-10 | Bluebird Bio, Inc. | VCN enhancer compositions and methods of using the same |
KR102387896B1 (ko) * | 2016-03-04 | 2022-04-15 | 더 보드 어브 트러스티스 어브 더 리랜드 스탠포드 주니어 유니버시티 | 프로스타글란딘 e2를 이용한 근육 재생을 위한 조성물 및 방법 |
US9918994B2 (en) | 2016-03-04 | 2018-03-20 | The Board Of Trustees Of The Leland Stanford Junior University | Compositions and methods for muscle regeneration using prostaglandin E2 |
EP4049665A1 (en) | 2016-03-15 | 2022-08-31 | Children's Medical Center Corporation | Methods and compositions relating to hematopoietic stem cell expansion |
WO2018093797A1 (en) | 2016-11-15 | 2018-05-24 | The Schepens Eye Research Institute, Inc. | Compositions and methods for the treatment of aberrant angiogenesis |
CN111050774A (zh) * | 2017-06-07 | 2020-04-21 | 中央研究院 | 移除未分化的万能性干细胞的方法 |
JP7372911B2 (ja) | 2017-06-09 | 2023-11-01 | ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー | 筋肉の状態を予防または治療するための組成物および方法 |
WO2019040448A1 (en) * | 2017-08-22 | 2019-02-28 | The Children's Medical Center Corporation | METHODS FOR INDUCING HEMATOPOIETIC STEM CELL SPECIFICITY |
WO2019060708A1 (en) | 2017-09-22 | 2019-03-28 | The Children's Medical Center Corporation | TREATMENT OF TYPE 1 DIABETES AND AUTOIMMUNE DISEASES OR DISORDERS |
JP7416700B2 (ja) | 2017-11-14 | 2024-01-17 | ザ スキーペンズ アイ リサーチ インスティチュート インコーポレイテッド | 増殖性硝子体網膜症および上皮間葉転換と関連付けられる状態の治療のためのrunx1阻害の方法 |
EP3597211A1 (en) * | 2018-07-19 | 2020-01-22 | Chemotherapeutisches Forschungsinstitut Georg-Speyer-Haus | Periostin compounds for the treatment of haematological complications |
CN109609455A (zh) * | 2018-12-28 | 2019-04-12 | 诺未科技(北京)有限公司 | 扩增造血干细胞的培养体系、方法及其用途 |
US20220127576A1 (en) * | 2019-02-13 | 2022-04-28 | Arizona Board Of Regents On Behalf Of The University Of Arizona | Compositions and methods for stem cell therapy |
CN110051839A (zh) * | 2019-04-16 | 2019-07-26 | 诺航生物技术(徐州)有限公司 | 一种促进脐带血干细胞体外扩增和增强脐带血干细胞移植后造血重建功能的药物 |
WO2021224633A1 (en) | 2020-05-06 | 2021-11-11 | Orchard Therapeutics (Europe) Limited | Treatment for neurodegenerative diseases |
US11883436B2 (en) | 2020-08-17 | 2024-01-30 | The Board Of Trustees Of The University Of Illinois | Method of preparing hematopoietic stem and progenitor cells for transplantation |
AU2021202658A1 (en) | 2021-04-28 | 2022-11-17 | Fondazione Telethon | Gene therapy |
GB202206346D0 (en) | 2022-04-29 | 2022-06-15 | Ospedale San Raffaele Srl | Gene therapy |
Family Cites Families (44)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA103846A (en) | 1906-12-03 | 1907-02-26 | William Bell | Manufacture of half-tone printing blocks |
US3217903A (en) | 1961-01-19 | 1965-11-16 | Mc Graw Edison Co | Segregating control |
US3753357A (en) | 1970-12-14 | 1973-08-21 | Ovitron Res Corp | Method and apparatus for the preservation of cells and tissues |
US4199022A (en) | 1978-12-08 | 1980-04-22 | The United States Of America As Represented By The Department Of Energy | Method of freezing living cells and tissues with improved subsequent survival |
US4239679A (en) | 1979-06-27 | 1980-12-16 | Diamond Shamrock Corporation | High bulk density rigid poly(vinyl chloride) resin powder composition and preparation thereof |
HU181154B (en) | 1980-07-18 | 1983-06-28 | Epitestudomanyi Intezet | Shaped building unit and space limiting or dividing structure made of same as well as method for producing the shaped building unit |
US4559298A (en) | 1982-11-23 | 1985-12-17 | American National Red Cross | Cryopreservation of biological materials in a non-frozen or vitreous state |
US5004681B1 (en) | 1987-11-12 | 2000-04-11 | Biocyte Corp | Preservation of fetal and neonatal hematopoietic stem and progenitor cells of the blood |
DE69033584T2 (de) * | 1989-10-16 | 2001-03-08 | Amgen Inc | Stammzellenfaktor |
US5114672A (en) | 1990-08-27 | 1992-05-19 | Cryo-Cell International, Inc. | Method for preserving blood fluid |
CA2168091A1 (en) * | 1993-08-23 | 1995-03-02 | Stephen L. Smith | In vitro growth of neutrophil and megakaryocyte precursors in serum-free media |
AU6125396A (en) * | 1995-06-07 | 1996-12-30 | Novartis Ag | Serum-free media for primitive hematopoietic cells and metho ds of use thereof |
US6372796B1 (en) | 1996-11-13 | 2002-04-16 | Cold Spring Harbor Laboratory | Therapeutic uses for nitric oxide inhibitors |
GB9904281D0 (en) * | 1999-02-24 | 1999-04-21 | Reneuron Ltd | Transplantation |
TWI247606B (en) | 1999-11-24 | 2006-01-21 | Ono Pharmaceutical Co | Treating agent for osteopenic diseases |
RU2259830C2 (ru) | 1999-11-24 | 2005-09-10 | Оно Фармасьютикал Ко., Лтд. | Фармацевтическая композиция для лечения заболеваний, связанных с потерей костной массы |
US6226997B1 (en) | 1999-12-07 | 2001-05-08 | Cryo-Cell International, Inc. | Method and device for maintaining temperature integrity of cryogenically preserved biological samples |
US6852534B2 (en) | 2000-11-03 | 2005-02-08 | Kourion Therapeutics Gmbh | Method to determine an engrafting cell dose of hematopoietic stem cell transplant units |
JP4077158B2 (ja) | 2001-01-10 | 2008-04-16 | 株式会社メニコン | 植物性繊維分解剤およびそれを用いた植物性廃棄物の処理法 |
EP2336300B1 (en) | 2001-02-14 | 2015-07-08 | Anthrogenesis Corporation | Post-partum mammalian placenta, its use and placental stem cells therefrom |
FR2825261B1 (fr) | 2001-06-01 | 2003-09-12 | Maco Pharma Sa | Ligne de prelevement du sang placentaire comprenant une poche de rincage |
US7179643B2 (en) | 2001-06-14 | 2007-02-20 | Reliance Life Sciences Pvt. Ltd. | Device and a process for expansion of haemopoeitic stem cells for therapeutic use |
JP4330995B2 (ja) | 2001-11-15 | 2009-09-16 | チルドレンズ メディカル センター コーポレーション | 絨毛膜絨毛、羊水、および胎盤からの胎児性幹細胞を単離、増殖、および分化させる方法、ならびにその治療的使用方法 |
CA2470707C (en) * | 2001-12-21 | 2014-07-08 | Mount Sinai Hospital | Cellular compositions and methods of making and using them |
RU2205627C1 (ru) * | 2002-05-30 | 2003-06-10 | Открытое акционерное общество "Косметическое объединение "Свобода" | Крем для лица, выводящий токсины |
ES2584606T3 (es) | 2002-10-10 | 2016-09-28 | Ono Pharmaceutical Co., Ltd. | Microesferas que comprenden ONO-1301 |
BRPI0408061A (pt) | 2003-03-04 | 2006-02-14 | Pfizer Prod Inc | tratamento médico utilizando um agonista de receptores seletivos de ep 2 |
CA2517959A1 (en) * | 2003-03-07 | 2004-09-16 | Gamida-Cell Ltd. | Expansion of renewable stem cell populations using modulators of pi 3-kinase |
US8029780B2 (en) | 2003-04-08 | 2011-10-04 | Yeda Research And Development Co. Ltd. | Stem cells having increased sensitivity to a chemoattractant and methods of generating and using same |
GB0324523D0 (en) * | 2003-10-21 | 2003-11-26 | Medical Res Council | Compositions and methods of treatment |
US8309608B2 (en) | 2003-11-06 | 2012-11-13 | Sanofi-Aventis Deutschland Gmbh | Use of eNOS transcription enhancers in the cell therapy of ischemic heart diseases |
IL158868A0 (en) | 2003-11-13 | 2004-05-12 | Yeda Res & Dev | Methods of generating and using stem cells enriched with immature primitive progenitor |
US20080299095A1 (en) * | 2004-07-09 | 2008-12-04 | Bc Cancer Agency | Nup98-Hox Fusions for Expansion of Hemopoietic Stem Cells |
US7147626B2 (en) | 2004-09-23 | 2006-12-12 | Celgene Corporation | Cord blood and placenta collection kit |
WO2006078886A2 (en) | 2005-01-18 | 2006-07-27 | Irm Llc | Compounds and compositions as wnt signaling pathway modulators |
US20090104159A1 (en) | 2005-02-10 | 2009-04-23 | Felipe Prosper | Vascular/Lymphatic Endothelial Cells |
US20080194024A1 (en) | 2005-07-29 | 2008-08-14 | Mays Robert W | Culture of Non-Embryonic Cells at High Cell Density |
JP4562618B2 (ja) | 2005-08-18 | 2010-10-13 | 陽一 佐藤 | 空き缶処理車 |
US8318489B2 (en) * | 2005-12-22 | 2012-11-27 | Bruce Paul Davidson | Prostacyclin directed differentiation of cardiomyocytes from human embryonic stem cells |
CN102626517B (zh) | 2006-03-24 | 2015-07-29 | 儿童医疗中心有限公司 | 调节造血干细胞生长的方法 |
EP2049129B1 (en) | 2006-06-22 | 2013-06-12 | Yeda Research And Development Co., Ltd. | Catecholamine receptor modulation |
US20100233135A1 (en) | 2006-08-16 | 2010-09-16 | The General Hospital Corporation | Compositions and methods for hematopoietic stem cell expansion or for modulating angiogenesis |
WO2008056963A1 (en) | 2006-11-10 | 2008-05-15 | Chanil Moon | Method for proliferating stem cells with leptin |
US9394520B2 (en) * | 2006-12-08 | 2016-07-19 | University Of Rochester | Expansion of hematopoietic stem cells |
-
2007
- 2007-03-26 CN CN201210050521.9A patent/CN102626517B/zh active Active
- 2007-03-26 CA CA2647201A patent/CA2647201C/en active Active
- 2007-03-26 ZA ZA200808123A patent/ZA200808123B/xx unknown
- 2007-03-26 EP EP07773772A patent/EP1999255A2/en not_active Withdrawn
- 2007-03-26 JP JP2009501606A patent/JP5247675B2/ja active Active
- 2007-03-26 EP EP20110004943 patent/EP2423303A1/en not_active Withdrawn
- 2007-03-26 WO PCT/US2007/007419 patent/WO2007112084A2/en active Application Filing
- 2007-03-26 EP EP18175819.4A patent/EP3424507A1/en active Pending
- 2007-03-26 MX MX2008012178A patent/MX2008012178A/es active IP Right Grant
- 2007-03-26 RU RU2011115827/10A patent/RU2493252C2/ru active
- 2007-03-26 AU AU2007230902A patent/AU2007230902B2/en active Active
- 2007-03-26 RU RU2008142106A patent/RU2425876C2/ru active
- 2007-03-26 CN CN200780018870XA patent/CN101495623B/zh active Active
- 2007-04-26 US US12/294,344 patent/US8168428B2/en not_active Expired - Fee Related
-
2008
- 2008-09-23 MX MX2019007494A patent/MX2019007494A/es unknown
-
2009
- 2009-09-21 ZA ZA200906574A patent/ZA200906574B/xx unknown
-
2012
- 2012-03-27 US US13/431,534 patent/US8551782B2/en active Active
- 2012-03-27 US US13/431,563 patent/US9028811B2/en active Active
- 2012-03-27 US US13/431,499 patent/US8563310B2/en active Active
-
2013
- 2013-01-22 HK HK13100952.1A patent/HK1173948A1/xx unknown
- 2013-03-08 JP JP2013046473A patent/JP6041711B2/ja active Active
- 2013-03-15 US US13/837,265 patent/US20130209424A1/en not_active Abandoned
- 2013-03-15 US US13/836,794 patent/US10278990B2/en active Active
- 2013-03-15 US US13/838,002 patent/US10272110B2/en active Active
-
2015
- 2015-07-27 JP JP2015147317A patent/JP6208719B2/ja active Active
-
2016
- 2016-09-08 JP JP2016175313A patent/JP6530732B2/ja active Active
-
2019
- 2019-02-19 JP JP2019027038A patent/JP6797222B2/ja active Active
- 2019-09-20 JP JP2019171346A patent/JP2019214620A/ja not_active Withdrawn
-
2021
- 2021-10-19 JP JP2021170835A patent/JP2022025091A/ja active Pending
-
2023
- 2023-06-16 JP JP2023098876A patent/JP2023112027A/ja active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1173948A1 (en) | Method to modulate hematopoietic stem cell growth | |
GB0710095D0 (en) | Culture method of stem cell | |
ZA201606403B (en) | Pluripotent stem cell culture on micro-carriers | |
GB2458863B (en) | Improved culture of stem cells | |
HK1216883A1 (zh) | 幹細胞培養 | |
PL2046946T3 (pl) | Hodowla pluripotencjalnych komórek macierzystych | |
EP2314671A4 (en) | STEM CELL CULTURE METHOD | |
SG138570A1 (en) | Growth of embryonic stem cells | |
ZA201000715B (en) | Single pluripotent stem cell culture | |
GB0901623D0 (en) | Method for stem cell culture and cells derived therefrom | |
ZA201000199B (en) | Algae growth for biofuels | |
ZA201006125B (en) | Composition for modulating stem cell growth with prostaglandins | |
GB0707089D0 (en) | Methods of increasing plant growth | |
EP2021464A4 (en) | METHOD FOR CULTURING HUMAN EMBRYONIC STEM CELLS | |
HK1137482A1 (en) | Improvement of cell growth | |
EP2092054A4 (en) | METHOD FOR CONTROLLING THE GROWTH OF A CELL CULTURE | |
EP2331676A4 (en) | GROWTH FACTOR OF A HEMATOPOIETIC STEM CELL | |
EP2294182A4 (en) | CULTS OF MULTIPOTENT STEM CELLS | |
EP2476748A4 (en) | CULTURE PROCESS FOR BLOOD-FORMING STEM CELLS | |
HUE036415T2 (hu) | Eljárás sejtnövekedés fokozására alkilamin-n-oxid (AANOx) alkalmazásával | |
AU2014201623B2 (en) | Pluripotent stem cell culture | |
GB0820167D0 (en) | Medium and method for growing stem cells | |
AU2008906186A0 (en) | Method of Storing Stem Cells | |
AU2007906462A0 (en) | Method of Storing Stem Cells | |
AU2008900312A0 (en) | Method & device to improve plant growth |